Insider trade

Officer exercised or converted 23K EW derivative securities

Traded Apr 2, 2026 · Filed Apr 2, 2026

Edwards LifesciencesEW

23K
Derivative units

Why it stands out

Derivative exercise or conversion — not an open-market buy.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Apr 2, 2026
Reporting period: Not applicable
Filed with the SEC: Apr 2, 2026

OfficerOption exercise

Context

Classification

option exercise

Code M — exercise or conversion of a derivative security

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001225208-26-004249

Filed / recorded

Apr 2, 2026, 9:13 PM UTC

Added to OQRO

Oct 2, 2026, 12:27 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

Edwards Lifesciences Corp

Issuer CIK

1099800

Ticker

EW

Reporting person

Donald E Jr Bobo

Relationship

Officer

Officer title

CVP,Strategy/Corp Development

Security

Employee Stock Option (Right to Acquire)

Table

Derivative (Table II)

Transaction date

Apr 2, 2026

Transaction code

M

Shares / units

22,680

Price per share

$0.00

Acquired / disposed

Disposed (D)

Shares owned after

0

Ownership form

Direct

Amendment

No

Around the same time

6mo ago

13KShares · @ $59.2567

Derivative exercise or conversion — not an open-market buy.

Why it stands out Official record

CFO sold ~$376K of Edwards Lifesciences

Scheduled in advance6mo ago

CFO sold ~$664K of Edwards Lifesciences

Scheduled in advance6mo ago